Mitsubishi Ufj Trust & Banking Corp Denali Therapeutics Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

  • $43.4 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$16.2 - $23.18 $725,274 - $1.04 Million
-44,770 Reduced 15.39%
246,190 $5.28 Million
Q3 2023

Nov 09, 2023
BUY
$20.63 - $30.17 $28,469 - $41,634
1,380 Added 0.48%
290,960 $6 Million
Q2 2023

Aug 08, 2023
SELL
$23.37 - $32.96 $351,718 - $496,048
-15,050 Reduced 4.94%
289,580 $8.55 Million
Q1 2023

May 10, 2023
BUY
$21.91 - $32.67 $60,471 - $90,169
2,760 Added 0.91%
304,630 $7.02 Million
Q4 2022

Feb 10, 2023
SELL
$26.28 - $33.92 $146,905 - $189,612
-5,590 Reduced 1.82%
301,870 $8.4 Million
Q3 2022

Nov 10, 2022
SELL
$25.97 - $38.53 $192,957 - $286,277
-7,430 Reduced 2.36%
307,460 $9.44 Million
Q1 2022

May 12, 2022
BUY
$29.0 - $47.27 $169,650 - $276,529
5,850 Added 1.89%
314,890 $10.1 Million
Q4 2021

Feb 09, 2022
SELL
$42.59 - $55.02 $1.26 Million - $1.63 Million
-29,690 Reduced 8.77%
309,040 $13.8 Million
Q3 2021

Nov 12, 2021
SELL
$48.48 - $78.23 $318,513 - $513,971
-6,570 Reduced 1.9%
338,730 $17.1 Million
Q2 2021

Aug 12, 2021
SELL
$50.3 - $78.44 $1.08 Million - $1.69 Million
-21,540 Reduced 5.87%
345,300 $27.1 Million
Q1 2021

May 12, 2021
SELL
$53.8 - $81.53 $193,142 - $292,692
-3,590 Reduced 0.97%
366,840 $20.9 Million
Q4 2020

Feb 12, 2021
SELL
$36.89 - $93.56 $984,225 - $2.5 Million
-26,680 Reduced 6.72%
370,430 $31 Million
Q3 2020

Nov 12, 2020
SELL
$23.13 - $38.84 $481,104 - $807,872
-20,800 Reduced 4.98%
397,110 $14.2 Million
Q2 2020

Aug 13, 2020
SELL
$16.01 - $28.82 $101,823 - $183,295
-6,360 Reduced 1.5%
417,910 $10.1 Million
Q1 2020

May 13, 2020
SELL
$14.2 - $27.98 $106,074 - $209,010
-7,470 Reduced 1.73%
424,270 $7.43 Million
Q4 2019

Feb 14, 2020
SELL
$14.4 - $19.99 $15,840 - $21,989
-1,100 Reduced 0.25%
431,740 $7.52 Million
Q3 2019

Nov 12, 2019
SELL
$15.32 - $21.92 $124,704 - $178,428
-8,140 Reduced 1.85%
432,840 $6.63 Million
Q2 2019

Aug 07, 2019
BUY
$18.5 - $28.14 $12,395 - $18,853
670 Added 0.15%
440,980 $9.16 Million
Q1 2019

May 13, 2019
SELL
$17.99 - $24.65 $3,777 - $5,176
-210 Reduced 0.05%
440,310 $10.2 Million
Q4 2018

Feb 12, 2019
SELL
$13.88 - $21.75 $695,249 - $1.09 Million
-50,090 Reduced 10.21%
440,520 $9.1 Million
Q3 2018

Nov 13, 2018
SELL
$12.46 - $21.74 $91,207 - $159,136
-7,320 Reduced 1.47%
490,610 $10.7 Million
Q2 2018

Aug 10, 2018
SELL
$15.25 - $21.02 $333,060 - $459,076
-21,840 Reduced 4.2%
497,930 $7.59 Million
Q1 2018

May 11, 2018
SELL
$15.36 - $24.8 $342,988 - $553,784
-22,330 Reduced 4.12%
519,770 $10.2 Million
Q4 2017

Feb 09, 2018
BUY
$15.04 - $21.45 $8.15 Million - $11.6 Million
542,100
542,100 $8.48 Million

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email